The Reason You Shouldn't Think About Making Improvements To Your ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The choice of whether to stop or continue ADHD medications during pregnancy and nursing is a challenge for women suffering from the condition. Little data exists about how long-term exposure to these medications could affect the fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological disorders like hearing loss or vision, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality studies.

Risk/Benefit Analysis

Pregnant women who take ADHD medications must weigh the benefits of using them against the risks to the fetus. Physicians do not have the data needed to make unequivocal recommendations but they can provide information about risks and benefits that aid pregnant women in making informed choices.

A study published in Molecular Psychiatry concluded that women who took ADHD medication during their early pregnancy did not have a higher risk of fetal malformations or structural birth defects. The researchers used a large population-based case-control study to evaluate the incidence of major structural birth defects in babies born to mothers who had taken stimulants in the early stages cost of adhd medication uk pregnancy, as well as those who had not. Clinical geneticists, pediatric cardiologists and other experts looked over the cases to make sure that the classification was correct and to reduce any bias.

However, the researchers' study was not without its flaws. The researchers were not able in the beginning to differentiate the effects of the medication from the disorder. This limitation makes it difficult to determine whether the small associations observed in the exposed groups are due to medication use or comorbidities that cause confusion. Researchers also did not study the long-term effects for the offspring.

The study did show that babies whose mothers had taken ADHD medication during pregnancy were at slightly higher risk of being admitted to the neonatal intensive care unit (NICU) than infants who were born without any medication or had taken off their medication prior to or during pregnancy. This was due to central nervous system-related disorders and the increased risk for admission did not appear to be influenced by which stimulant medication was used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher chance of having to have caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases didn't appear to be influenced by the kind of medication used during pregnancy.

The research suggests that the low risk associated with the use of ADHD medications during early pregnancy could be offset by the greater benefit for both mother and child of continued treatment for the woman's disorder. Physicians should discuss this with their patients and, where they are able, assist them in developing strategies for improving their coping skills that may minimize the effects of her disorder on her daily functioning and relationships.

Medication Interactions

Many doctors are confronted with the dilemma of whether to maintain treatment or stop as more women are diagnosed with ADHD. Most of the time, these decisions are made without any evidence that is clear and definitive in either case, which means that doctors have to weigh their experience about their experiences, the experiences of other doctors, and what research suggests on the subject and their best non stimulant adhd medication for adults judgment for each patient.

Particularly, the subject of potential risks for the baby can be tricky. Many studies on this subject are based on observations instead of controlled research and their conclusions are often contradictory. The majority of studies focus on live births, which may underestimate the severity of teratogenic effects leading to terminations or abortions of pregnancy. The study that is discussed in the journal club addresses these issues by analyzing information on deceased and live births.

The conclusion The conclusion: While certain studies have demonstrated that there is a positive correlation between ADHD medications and the risk of certain birth defects, other studies have not found any evidence of a link, and most studies show a neutral or even slightly negative effect. In all adhd medications cases it is imperative to conduct a thorough analysis of the benefits and risks must be performed.

For a lot of women with ADHD and ADD, the decision to stop medication is difficult, if not impossible. In a recent piece published in the Archives of Women's Mental Health by psychologist Jennifer Russell, she notes that stopping ADHD medications during pregnancy can increase depression and feelings of being isolated. The loss of medication can affect the ability to safely drive and to perform work-related tasks which are essential aspects of everyday life for people with ADHD.

She suggests that women who are unsure about whether to continue or stop taking medication because of their pregnancy, consider the possibility of educating friends, family members, and coworkers on the condition, its impact on daily life, and the advantages of continuing the current treatment regimen. It can also help the woman feel supported in her struggle with her decision. Certain medications can be passed through the placenta. If a woman decides to not take her ADHD medication while breastfeeding, it is important to be aware that the medication may be transferred to her baby.

Risk of Birth Defects

As the use of ADHD medications to treat symptoms of attention deficit hyperactivity disorder (ADHD) grows there are concerns about what impact the drugs could have on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body of knowledge regarding this topic. Using two massive data sets researchers were able to examine more than 4.3 million pregnancies and determine whether stimulant medication use increased the risk of birth defects. Researchers found that while the overall risk is low, the first trimester ADHD medication use was associated with slightly higher rates of specific heart defects like ventriculoseptal defect.

The authors of the study could not discover any link between early medication usage and other congenital anomalies, like facial deformities, or club feet. The results are in line with previous studies showing a small but significant increase in the risk of cardiac malformations among women who started taking ADHD medications prior to the birth of their child. This risk increased during the latter part of pregnancy when a large number of women began to stop taking their medication.

Women who were taking ADHD medication during the first trimester were more likely to need a caesarean or have an insufficient Apgar after delivery, and have a baby who needed help breathing at birth. The authors of the study could not remove bias in selection since they restricted the study to women who did not have any other medical conditions that could have contributed to the findings.

The researchers hope that their research will aid in the clinical decisions of doctors who treat pregnant women. The researchers recommend that, while discussing benefits and risks are important, the choice about whether to continue or stop medication should be made according to the severity of each woman's ADHD symptoms and the needs of the woman.

The authors also advise that while discontinuing the medications is an alternative, it is not an option that is recommended due to the high rate of depression and other mental health problems in women who are pregnant or who are recently postpartum. Further, the research suggests that women who decide to stop taking their medication are more likely to experience difficulties adapting to life without them after the birth of their baby.

Nursing

It can be a stressful experience becoming a mother. Women who suffer from ADHD can face severe challenges when they have to manage their symptoms, go to doctor appointments, prepare for the birth of a baby and adjust to new routines. Many women opt to continue taking their different adhd medications medication during pregnancy.

The risk to breastfeeding infant is minimal because the majority of stimulant medications passes through breast milk in low amounts. The rate of exposure to medication will differ based on dosage, frequency of administration and the time of day. In addition, what medication is prescribed for adhd individual medications enter the baby's system differently through the gastrointestinal tract and breast milk. The impact of this on a newborn infant is not yet fully understood.

Because of the lack of research, some doctors may be inclined to discontinue stimulant medications during a woman's pregnancy. This is a difficult choice for the patient, who must weigh the benefit of continuing her medication against the potential dangers to the fetus. Until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and if they plan or are taking to take medication during the perinatal time.

A increasing number of studies have revealed that women can continue taking their ADHD medication during pregnancy and while breastfeeding. This has led to many patients opt to do this and in consultation with their physician, they have found that the benefits of continuing their current medication outweigh any potential risks.

Women who suffer from ADHD who plan to breastfeed should seek advice from a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their physician and discuss the advantages and disadvantages of continuing treatment, including non-pharmacological strategies. Psychoeducation is also needed to help pregnant women with adhd inattentive type medication recognize the signs and the underlying disorder. They should also learn about treatment options and reinforce the coping mechanisms. This should be a multidisciplinary effort together with obstetricians, GPs, and psychiatry. The pregnancy counselling should consist of discussion of a management plan for both the mother and child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.